Research progress of anti-pulmonary fibrosis drugs targeting autotaxin-lysophosphatidic acid axis
1. New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
2. College of Pharmacy, Shaanxi University of Traditional Chinese Medicine, Xianyang 712046, China
3. NMPA Key Laboratory for Safety Research and Evaluation of Innovative Drug, Beijing 102206, China
4. Beijing Union-Genius Pharmaceutical Technology Development Co. Ltd., Beijing 100176, China
收起